Health FDA Approves Romvimza: New Oral Treatment for Rare Joint TumorBy Stanley SimalsFebruary 20, 2025 Health 3 Mins Read The FDA has approved vimseltinib, a new oral medication designed to treat tenosynovial giant cell tumor (TGCT), a rare, noncancerous…
